慢性脑室内注射1-甲基-4-苯基吡啶鎓作为帕金森病的渐进模型。
Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease.
作者信息
Sonsalla Patricia K, Zeevalk Gail D, German Dwight C
机构信息
Department of Neurology, Robert Wood Johnson Medical School/UMDNJ, 675 Hoes Lane, Piscataway, NJ 08854, USA.
出版信息
Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S116-8. doi: 10.1016/j.parkreldis.2008.04.008. Epub 2008 Jun 25.
Abstract
Animal models of Parkinson's disease (PD) that more closely exhibit the chronic neuropathology seen in the human condition are needed in order to reveal processes involved with progressive neurodegeneration and for testing potential interventions for retarding dopamine (DA) neuronal loss. Here we describe the recently developed chronic rat model of PD in which 1-methyl-4-phenylpyridinium ion (MPP(+)) is infused chronically into the lateral cerebral ventricle. We review features of this model that include loss of nigral DA neurons, swollen and abnormal mitochondria, striatal inclusion-like bodies and microgliosis. Advantages as well as limitations of the model are addressed.
摘要
为了揭示与进行性神经退行性变相关的过程以及测试延缓多巴胺（DA）神经元丢失的潜在干预措施，需要更紧密地展现人类帕金森病（PD）慢性神经病理学特征的动物模型。在此，我们描述了最近开发的慢性大鼠PD模型，其中1-甲基-4-苯基吡啶离子（MPP(+)）被长期注入大脑侧脑室。我们回顾了该模型的特征，包括黑质DA神经元丢失、线粒体肿胀和异常、纹状体包涵体样小体以及小胶质细胞增生。还讨论了该模型的优点和局限性。
相似文献
1
Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease.慢性脑室内注射1-甲基-4-苯基吡啶鎓作为帕金森病的渐进模型。
Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S116-8. doi: 10.1016/j.parkreldis.2008.04.008. Epub 2008 Jun 25.
2
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).帕金森病大鼠模型：1-甲基-4-苯基吡啶离子（MPP+）的慢性中枢给药
Exp Neurol. 2006 Jul;200(1):172-83. doi: 10.1016/j.expneurol.2006.02.002. Epub 2006 Mar 20.
3
A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.一种通过脑室内注射1-甲基-4-苯基吡啶鎓来培育帕金森病猕猴（食蟹猴）的定量方法。
J Neurosci Methods. 2015 Aug 15;251:99-107. doi: 10.1016/j.jneumeth.2015.05.008. Epub 2015 May 21.
4
IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.IL-17A 通过激活帕金森病啮齿动物模型中的小胶质细胞加剧神经炎症和神经退行性变。
Brain Behav Immun. 2019 Oct;81:630-645. doi: 10.1016/j.bbi.2019.07.026. Epub 2019 Jul 24.
5
7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.7-硝基吲唑保护纹状体多巴胺能神经元免受1-甲基-4-苯基吡啶离子（MPP+）诱导的变性：一项体内微透析研究。
Ann N Y Acad Sci. 2006 Nov;1089:462-71. doi: 10.1196/annals.1386.015.
6
Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats.通过微透析技术对自由活动大鼠纹状体内单次注射6-羟基多巴胺或1-甲基-4-苯基吡啶鎓的慢性影响进行研究。
Brain Res. 1995 Oct 16;695(2):151-7. doi: 10.1016/0006-8993(95)00705-u.
7
Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease.以 SNc 区小胶质细胞 NLRP3 为靶点作为治疗帕金森病的一种有前景的疾病修饰疗法。
Brain Behav. 2022 Nov;12(11):e2784. doi: 10.1002/brb3.2784. Epub 2022 Oct 5.
8
Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.直接向黑质内注射多巴色素会导致多巴胺能神经元变性。
Neurosci Lett. 2016 Jan 26;612:178-184. doi: 10.1016/j.neulet.2015.12.028. Epub 2015 Dec 15.
9
1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C.1-甲基-4-苯基吡啶鎓通过激活半胱天冬酶和蛋白激酶C影响快速轴突运输。
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2442-7. doi: 10.1073/pnas.0611231104. Epub 2007 Feb 7.
10
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.环境风险因素与帕金森病：除草剂百草枯导致黑质多巴胺能神经元的选择性退化
Neurobiol Dis. 2002 Jul;10(2):119-27. doi: 10.1006/nbdi.2002.0507.
引用本文的文献
1
Identification of copper metabolism-related markers in Parkinson's disease.帕金森病中铜代谢相关标志物的鉴定。
Ann Med. 2024 Dec;56(1):2425064. doi: 10.1080/07853890.2024.2425064. Epub 2024 Nov 18.
2
Adenosine A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson's Disease.腺苷 A 受体阻断在帕金森病大鼠模型中，在明显神经退行性变之前而非之后，提供更有效的益处。
Int J Mol Sci. 2024 Apr 30;25(9):4903. doi: 10.3390/ijms25094903.
3
UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib.UBL3在细胞中与α-突触核蛋白相互作用，且这种相互作用被表皮生长因子受体（EGFR）途径抑制剂奥希替尼下调。
Biomedicines. 2023 Jun 10;11(6):1685. doi: 10.3390/biomedicines11061685.
4
Zfra Inhibits the TRAPPC6AΔ-Initiated Pathway of Neurodegeneration.Zfra 抑制由 TRAPPC6AΔ 引发的神经退行性病变通路。
Int J Mol Sci. 2022 Nov 22;23(23):14510. doi: 10.3390/ijms232314510.
5
Altered expression of miR-29a-3p and miR-34a-5p by specific inhibition of GSK3β in the MPP treated SH-SY5Y Parkinson's model.在MPP处理的SH-SY5Y帕金森病模型中，通过特异性抑制GSK3β改变miR-29a-3p和miR-34a-5p的表达。
Noncoding RNA Res. 2022 Jan 7;7(1):1-6. doi: 10.1016/j.ncrna.2021.12.004. eCollection 2022 Mar.
6
Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4'I-MPP.通过荧光模拟物 4'I-MPP 研究 MPP+的线粒体和细胞摄取特征。
PLoS One. 2018 Aug 23;13(8):e0197946. doi: 10.1371/journal.pone.0197946. eCollection 2018.
7
Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress.生长因子和神经球蛋白在星形胶质细胞对抗神经变性和氧化应激中的保护作用。
Mol Neurobiol. 2019 Apr;56(4):2339-2351. doi: 10.1007/s12035-018-1203-9. Epub 2018 Jul 7.
8
Intracerebroventricularly-administered 1-methyl-4-phenylpyridinium ion and brain-derived neurotrophic factor affect catecholaminergic nerve terminals and neurogenesis in the hippocampus, striatum and substantia nigra.脑室内注射1-甲基-4-苯基吡啶离子和脑源性神经营养因子会影响海马体、纹状体和黑质中的儿茶酚胺能神经末梢和神经发生。
Neural Regen Res. 2018 Apr;13(4):717-726. doi: 10.4103/1673-5374.230300.
9
P-Glycoprotein Transport of Neurotoxic Pesticides.神经毒性农药的P-糖蛋白转运
J Pharmacol Exp Ther. 2015 Oct;355(1):99-107. doi: 10.1124/jpet.115.226373. Epub 2015 Aug 13.
10
2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.2,2'-和4,4'-花菁是不依赖转运体的体外多巴胺能毒素，其特异性和毒性机制与MPP⁺相似。
J Neurochem. 2015 Nov;135(4):755-67. doi: 10.1111/jnc.13201. Epub 2015 Aug 12.
本文引用的文献
1
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease.谷胱甘肽单乙酯和谷胱甘肽对脑及神经元培养物中谷胱甘肽（GSH）细胞内升高的表征：与帕金森病的相关性
Exp Neurol. 2007 Feb;203(2):512-20. doi: 10.1016/j.expneurol.2006.09.004. Epub 2006 Oct 17.
2
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).帕金森病大鼠模型：1-甲基-4-苯基吡啶离子（MPP+）的慢性中枢给药
Exp Neurol. 2006 Jul;200(1):172-83. doi: 10.1016/j.expneurol.2006.02.002. Epub 2006 Mar 20.
3
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.连续输注MPTP诱导的帕金森样综合征：泛素-蛋白酶体系统与α-突触核蛋白的协同作用
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3413-8. doi: 10.1073/pnas.0409713102. Epub 2005 Feb 16.
4
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.用MPTP处理后，人α-突触核蛋白转基因小鼠黑质线粒体病理增强。
Exp Neurol. 2004 Apr;186(2):158-72. doi: 10.1016/S0014-4886(03)00342-X.
5
Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.帕金森病小鼠模型：亚急性MPTP与慢性MPTP/丙磺舒治疗的比较
Neuroscience. 2001;106(3):589-601. doi: 10.1016/s0306-4522(01)00295-0.
6
Chronic systemic pesticide exposure reproduces features of Parkinson's disease.长期全身性接触农药会重现帕金森病的特征。
Nat Neurosci. 2000 Dec;3(12):1301-6. doi: 10.1038/81834.
7
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.散发性帕金森病和阿尔茨海默病胞质杂种细胞系中的线粒体形态异常。
Exp Neurol. 2000 Mar;162(1):37-50. doi: 10.1006/exnr.2000.7333.
8
Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.食蟹猴1-甲基-4-苯基-1,2,3,6-四氢吡啶的神经病理学研究
Acta Neuropathol. 1988;75(4):370-6. doi: 10.1007/BF00687790.
9
Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）处理的小鼠中黑质、腹侧被盖区和纹状体的超微结构变化
Res Commun Chem Pathol Pharmacol. 1990 Mar;67(3):307-20.
Zotero 插件